ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Weak Electromagnetic Fields Can Possibly Stabilize Tumors

September 30, 2011

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Computer Interpretation Software Does Not Improve Detection

August 26, 2011

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept

May 22, 1981

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014